The Israeli pharmaceutical giant's CEO Erez Vigodman retains the board's support even though the company's share has lost half its value. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA ; TASE: TEVA ) is often regarded as the flagship of Israeli ... Globes, 2 weeks ago
The 39th Annual San Antonio Breast Cancer Symposium The annual San Antonio Breast Cancer Symposium was held from Dec. 6 to 10 and attracted more than 7,500 participants from around the world, including medical oncologists, radiation oncologists, ...Doctors Lounge, 1 month ago
SANANTONIO — The potential expansion of treatment options in metastatic breast cancer sometimes comes in a mixed bag. Take the case of investigational PI3K inhibitor buparlisib (BKM120). Adding this agent to fulvestrant in postmenopausal women ...General Medicine eJournal, 1 month ago
SABCS 2016: Trial of presurgery abemaciclib treatment for early-stage HR-pos/HER2-neg breast cancer met primary endpoint
Presurgery treatment with the investigational therapeutic abemaciclib, either alone or in combination with the aromatase inhibitor anastrozole, reduced levels of Ki67, a marker of cell proliferation, in hormone receptor (HR)-positive, HER2-negative ...Ecancer Medicalscience, 1 month ago Phase II Trial of Presurgery Abemaciclib Treatment for Early-stage HR-positive, HER2-negative Breast Cancer Met Primary Endpoint American Association for Cancer Research, 1 month ago
on your WebpageAdd Widget >Get your members hooked!